Equity Capital Markets

Company · CIK 1842295

Maze Therapeutics, Inc.

CIK1842295 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedMAZE (Nasdaq)
First annual or quarterly report2025-03-31

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-290935
Registered companyEffective
 2025-10-172026-05-132
333-293206
ShelfEffective
 2026-02-042026-04-222
333-284164
IPOFinal prospectus
 2025-01-072025-01-315

Filings

10
FiledFilingRegistrationAccession
2026-05-13EFFECTDeclared effective 333-2909359999999995-26-001606
2026-04-22424B5Shelf takedown 333-2932060001193125-26-170687
2026-02-04S-3ASRShelf registered 333-2932060001193125-26-037831
2025-10-17S-1Registration filed 333-2909350001193125-25-242526
2025-01-31424B4Final prospectus 333-2841640001193125-25-018482
2025-01-30EFFECTDeclared effective 333-2841649999999995-25-000242
2025-01-30S-1/AAmendment 333-2841640001193125-25-016039
2025-01-27S-1/AAmendment 333-2841640001193125-25-012638
2025-01-07S-1Registration filed 333-2841640001193125-25-002851
2024-06-21DRSDraft made public 377-072950000950123-24-006286

All filings of this company · CSV